NHS LPP - Health and Social Care Apps DPS

  • Guy's and St Thomas' NHS Foundation Trust

F14: Notice for changes or additional information

Notice reference: 2024/S 000-012435

Published 17 April 2024, 8:45am



Section one: Contracting authority/entity

one.1) Name and addresses

Guy's and St Thomas' NHS Foundation Trust

Great Maze Pond

London

SE1 9RT

Contact

shahajan miah

Email

CDS@gstt.nhs.uk

Telephone

+44 7985633733

Country

United Kingdom

NUTS code

UKI44 - Lewisham and Southwark

Internet address(es)

Main address

https://www.lpp.nhs.uk/

Buyer's address

https://www.lpp.nhs.uk/


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

NHS LPP - Health and Social Care Apps DPS

Reference number

DN435342

two.1.2) Main CPV code

  • 48000000 - Software package and information systems

two.1.3) Type of contract

Supplies

two.1.4) Short description

The original CONTRACT NOTICE (04/10/2019) 2019/s 192-45638 https://ted.europa.eu/udl?uri=TED:NOTICE:465638-2019:TEXT:EN:HTML. The DPS was initial awarded 2019 and is still open to new applications.

Original short description as published in notice 2021/s 221-584062:
The London Procurement Partnership is advertising for suppliers for a health and social care applications dynamic purchasing system.
The purpose of this DPS will be to provide the public sector with a mechanism to procure safe and clinically beneficial applications to meet their health and social care needs supporting patients, clinicians and non-clinical staff.
The initial categories covered under this DPS are:
Category 1: Child health,
Category 2: Diabetes and hormones,
Category 3: Heart/blood vessels,
Category 4: Mental health,
Category 5: Pregnancy,
Category 6: Brain/nerves,
Category 7: Cancer,
Category 8: Healthy living,
Category 9: Joints/bone/muscle,
Category 10: Medicines and clinical reference,
Category 11: Covid-19 Support solutions,
Category 12: Chest and lung,
Category 13 – Blood,
Category 14 – Dental,
Category 15 – Ear / Nose / Throat / Mouth,
Category 16 – Education,
Category 17 – Eyes,
Category 18 – First Aid,
Category 19 – Gastrointestinal,
Category 20 – Kidney / Genito-Urinary,
Category 21 – Men’s Health,
Category 22 – Sexual Health,
Category 23 – Skin,
Category 24 – Tropical Diseases,
Category 25 – Woman’s Health.
Please note that the categories have been split further in to subcategories (please refer to the document pack
for further information).
This OJEU notice is a republished notice from the original — 2019/S 192-465638.
A notice was also published for categories 5-10 — 2020/S 042-100524

This is an extension of the DPS with multiple supplier awards. For the list of awarded suppliers please click on the link https://healthappsdps.orcha.co.uk/

DPS Extension as permitted under PCR 2015 and allowed for within the original procurement documents at the DPS initiation
Original CONTRACT NOTICE (04/10/2019) 2019/s 192-45638


Section six. Complementary information

six.6) Original notice reference

Notice number: 2022/S 000-031382


Section seven. Changes

seven.1) Information to be changed or added

seven.2) Other additional information

NHS London Procurement Partnership will add an additional category to the existing Health Apps DPS;Category 26 – NICE Accredited Apps An evidence-based therapeutic intervention delivered through software to prevent, manage, or treat a medical disorder or disease. They are typically accessed via a smartphone app or online and engage the patient without the involvement of a clinician.The evidence-based therapeutic intervention must be registered as a medical device and must be regulated by the MHRA for use in the UK. The evidence-based therapeutic intervention must be compliant with the Digital Technology Assessment Criteria (DTAC).Sub-Category 26.1 – Digital cognitive behavioural therapy for adults with insomniaDigital cognitive behavioural therapy for adults with insomnia. An evidence-based therapeutic intervention delivered through software to prevent, manage, or treat insomnia and insomnia symptoms. This intervention will be accessed via a smartphone app or online and engage the patient without the need for prescription or referral. The evidence-based therapeutic intervention and its use in providing care and treatment to users should meet all relevant regulatory requirements. The evidence-based therapeutic intervention must either possess existing proprietary Randomised Controlled Trial (RCT) or Real World (RWE) evidence demonstrating safety and efficacy or have plans to generate such evidence1. The evidence-based therapeutic intervention must be compliant with the Digital Technology Assessment Criteria (DTAC).NICE Early Evaluation Assessment (EVA) products only